Within a few years the reduced deuterium content preparation can be an anti-cancer drug
The AHYD Rákkutató és Gyógyszerfejlesztő Kft. (AHYD Cancer Research and Drug Development Ltd.) has taken another significant step towards the registration of the reduced deuterium content water (DDW) as an anticancer medicine.
The total value of the world-wide unique pharmaceutical investment is more than 250 million HUF. The investment was implemented with the help of the Primus Capital Kockázati Tőkealap-kezelő Zrt. (Primus Capital Venture Capital Fund Management Ltd.). The European Union also supported the project with 16.644 million HUF.
Related news
There is bad news about ultra-processed foods
One of the worrying trends in modern nutrition is the…
Read more >It is not healthy to always eat the same thing for breakfast and dinner
Eating the same diet every day in the morning and…
Read more >Related news
Henkel delivers good organic sales growth and very strong earnings improvement in first half of 2024
In the first half of 2024, Henkel recorded good organic…
Read more >PENNY stores only close on August 20th
You can conveniently do your shopping even on the holiday…
Read more >Resolution regarding the GVH procedure initiated against Szentkirályi Hungary
Yesterday, the Economic Competition Authority (GVH) announced in a press…
Read more >